Management Strategies for Hepatotoxicity Associated With Elexacaftor/Tezacaftor/Ivacaftor: Results of a Provider Survey.

Kam CW, Bullington W, Elliott A, Faircloth JM, Huntman J, Jacobs HR, Poisson MO, Garcia S, Witte J, McKinzie CJ

DOI: 10.1002/ppul.71778
Published: 2026 Aug
Container: Pediatric pulmonology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ppul.71778,
  title = {Management Strategies for Hepatotoxicity Associated With Elexacaftor/Tezacaftor/Ivacaftor: Results of a Provider Survey.},
  author = {Kam CW and Bullington W and Elliott A and Faircloth JM and Huntman J and Jacobs HR and Poisson MO and Garcia S and Witte J and McKinzie CJ},
  year = {2026},
  journal = {Pediatric pulmonology},
  doi = {10.1002/ppul.71778},
  url = {https://doi.org/10.1002/ppul.71778}
}

RIS

TY  - JOUR
TI  - Management Strategies for Hepatotoxicity Associated With Elexacaftor/Tezacaftor/Ivacaftor: Results of a Provider Survey.
AU  - Kam CW
AU  - Bullington W
AU  - Elliott A
AU  - Faircloth JM
AU  - Huntman J
AU  - Jacobs HR
AU  - Poisson MO
AU  - Garcia S
AU  - Witte J
AU  - McKinzie CJ
PY  - 2026
JO  - Pediatric pulmonology
DO  - 10.1002/ppul.71778
UR  - https://doi.org/10.1002/ppul.71778
ER  -

APA

CW, K., W, B., A, E., JM, F., J, H., HR, J., MO, P., S, G., J, W., & CJ, M. (2026). Management Strategies for Hepatotoxicity Associated With Elexacaftor/Tezacaftor/Ivacaftor: Results of a Provider Survey.. Pediatric pulmonology. https://doi.org/10.1002/ppul.71778

Source records

pubmed · retrieved 2026-09-26T08:10:06.732Z
europe-pmc · retrieved 2026-09-26T08:10:06.759Z